RCS - Inspiration Health - Conference attendance at Mello2026 Investor event
RNS Number : 6068CInspiration Healthcare Group PLC11 November 2026
Inspiration Healthcare Group plc
(“Inspiration Healthcare”, the “Company” or the “Group”)
Conference attendance at Mello2026 Investor event
Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, announces that Inspiration Healthcare will be presenting at the Mello2026 investor event on Tuesday 17 November, which will be held at The Clayton Hotel & Conference Centre, Chiswick High Road, London, W4 5RY.
Raffi Stepanian, CEO, and Alan Olby, CFO, will be presenting at 11:15am and 14:25pm on the day, providing an overview of the Company and strategy. No new information will be disclosed at the event, and a PDF of the presentation will be made available on the Company’s website at https://inspirationhealthcaregroup.com/category/news/presentations/.
For further information and tickets for the Mello2026 conference, please visit the event website at https://www.melloevents.com/mellolondon2026.
For further information, please contact:
Inspiration Healthcare Group plc
Tel: +44 (0)20 7496 3000
Raffi Stepanian, Chief Executive Officer
Alan Olby, Chief Financial Officer
Singer Capital Markets (Nominated Adviser & Broker)
Tel: +44 (0)20 7496 3000
Alex Bond
Graham Hertrich
Patrick Weaver
Cavendish Capital Markets (Joint Broker)
Tel: + 44 (0)20 7220 0500
Giles Balleny / Joe Smith
Nigel Birks
Harriet Ward
Walbrook PR Ltd (Media & IR)
Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com
Anna Dunphy
Mob: +44 (0) 7876 741 001
Rachel Broad
Mob: +44 (0) 7747 515 393
About Inspiration Healthcare
Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering medical technology. Based in the UK, the Company specialises in neonatal intensive care medical devices, which are addressing a critical need to help to save the lives and improve the outcomes of patients, starting with the very first breaths of life.
The Company has a broad portfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support through to single-use disposables.
The Company sells its products directly to hospitals and healthcare providers in the UK and Ireland, where it also distributes a range of advanced medical technologies for infusion therapy. In the rest of the world the Company has an established network of distribution partners around the world giving access to more than 75 countries.
The Company operates in the UK from its world-class Manufacturing and Technology Centre in Croydon, South London and in the USA from its facility in Melbourne, Florida.
Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDNRAMZMMMVGZGVZM
Recent news on Inspiration Healthcare
See all newsRCS - Inspiration Health - Conference attendance at Mello2026 Investor event
UK's Inspiration Healthcare H1 underlying revenue rises on neonatal ventilation segment
Brief: Inspiration Healthcare H1 Gross Margin 41.9%
Inspiration Health - Half-year Financial Report
Inspiration Health - Holding(s) in Company
